Roche signs research pact with Merck
By New Statesman - 18 February 11:01

Roche Molecular Systems has signed a research collaboration deal with Merck Sharp & Dohme (Merck), a

Cooper Surgical acquires Her Option product line from American Medical Systems
By New Statesman - 17 February 10:47

CooperSurgical, the women's healthcare unit of Cooper Companies, has acquired the Her Option global

Teva reports 33% rise in Q4 net sales
By New Statesman - 17 February 10:46

Teva Pharmaceutical has reported net sales of $3.8 billion for the fourth quarter of 2009 compared t

Octapharma commences Phase III studies of IVIG
By New Statesman - 17 February 10:44

Octapharma has initiated first of a series of Phase III studies for its new 10% high purity intraven

Solvay becomes part of Abbott's global pharmaceutical products group
By New Statesman - 17 February 10:43

Abbott has added an additional portfolio of complementary pharmaceutical products to its portfolio b

AstraZeneca enters into license agreement with Rigel
By New Statesman - 17 February 10:42

AstraZeneca has entered into a worldwide license agreement with Rigel Pharmaceuticals for the develo

GE Healthcare unveils Vscan visualisation tool
By New Statesman - 16 February 10:17

GE Healthcare has introduced Vscan, a pocket-sized visualisation tool developed to provide physician

Isogenica partners UK Ministry of Defence agency
By New Statesman - 16 February 10:10

Isogenica has entered into an agreement with the Ministry of Defence agency and the Defence Science

Sinovac expands production capacity
By New Statesman - 16 February 10:06

Sinovac Beijing, a subsidiary of China-based vaccine manufacturer Sinovac Biotech (Sinovac), has acq

Proteonomix establishes new subsidiary
By New Statesman - 15 February 11:44

Proteonomix has formed a wholly-owned subsidiary, Proteonomix Regenerative Translational Medicine In

Epic Wound Care ships wound care product to Israel
By New Statesman - 15 February 11:43

United EcoEnergy (UEEC) has reported that its principal operating subsidiary, Epic Wound Care, has c

Qiagen seals distribution agreement with Celera
By New Statesman - 12 February 10:45

Qiagen and Celera have signed an agreement under which Qiagen will distribute a Celera molecular mul

FDA approves heat-stable Norvir tablets from Abbott
By New Statesman - 12 February 10:41

Abbott has announced that the FDA has granted approval of a new tablet formulation of it's antiretro

ReNeuron receives approval to initiate stroke trial
By New Statesman - 11 February 11:12

ReNeuron has announced that the UK Gene Therapy Advisory Committee (GTAC) has given a full and final

St Jude Medical receives European CE Mark for Merlin@home transmitter
By Staff blogger - 11 February 11:10

St Jude Medical has received European CE Mark approval for USB cellular adaptor for the Merlin@home

Elder Pharmaceuticals opens new manufacturing facility in India
By New Statesman - 11 February 11:08

Mumbai, India-based Elder Pharmaceuticals has commenced a new manufacturing facility in Dehradun, In

FDA accepts Psyadon IND in LND trial
By New Statesman - 10 February 10:32

Psyadon Pharmaceuticals has announced that the FDA has accepted its Investigational New Drug Applica

Pharmaxis completes acquisition of Topigen
By New Statesman - 10 February 10:27

Pharmaxis has issued 3.2m shares on completion of the acquisition of Canada-based private biopharmac

FDA postpones review meeting for Pixantrone
By New Statesman - 10 February 10:25

FDA has informed Cell Therapeutics (CTI) that due to severe weather conditions in the Washington DC

Luxottica, Essilor form JV for ANZ
By New Statesman - 09 February 11:36

Luxottica Group (Luxottica) and Essilor International (Essilor) have formed a long-term joint-ventur

Lupin receives FDA approval for Amlodipine/Benazepril capsules
By New Statesman - 09 February 11:27

Lupin has received final approval for Amlodipine/Benazepril 2.5mg/10mg, 5mg/10mg, 5mg/20mg and 10mg/

GSK forms new specialized R&D unit
By New Statesman - 09 February 11:21

GSK has established a new standalone unit specialising in the development and commercialisation of m

European Commission approves Almirall's BPH drug
By New Statesman - 09 February 11:20

Almirall has reported that the European Commission has granted a marketing authorisation for Silodos

Lupin receives FDA approval for Amlodipine/Benazepril capsules
By New Statesman - 09 February 11:03

The Amlodipine/Benazepril capsules are the AB rated generic equivalent of Novartis' Lorrel capsules

GSK forms new specialized R&D unit
By New Statesman - 09 February 11:01

GSK has established a new standalone unit specialising in the development and commercialisation of m

European Commission approves Almirall's BPH drug
By New Statesman - 09 February 10:58

Almirall has reported that the European Commission has granted a marketing authorisation for Silodos

Bayer, Biocon form strategic partnership
By New Statesman - 08 February 11:01

Biocon and Bayer Healthcare, a subsidiary of Bayer AG, have entered into a strategic partnership for

Riken, Fukuoka University report HMGB1 Protein triggers Islet cell rejection
By New Statesman - 08 February 10:58

Researchers at Riken and Fukuoka University have pinpointed the mechanism responsible for early reje

Prima BioMed initiates Phase IIb CVac trial
By New Statesman - 08 February 10:56

Prima BioMed has provided updates on the continuing progress towards commercialising its core produc

BioMarin updates on Morquio trial
By New Statesman - 08 February 10:55

BioMarin Pharmaceutical (BioMarin) has updated on the phase I/II trial for BMN 110 or N-acetylgalact

Pages